Search research articles
Contact Us
Filters
Showing results (11-20 of 587) with videos related to
Page
of 59
Sort By:
Pathologie-Biologie
|
November 1, 1974
[Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen]
J Soria, C Soria
The New England Journal of Medicine
|
December 26, 2001
Anticoagulation for idiopathic deep-vein thrombosis
J P Kévorkian, C Soria
Bulletin Du Cancer
|
December 28, 1999
[Evaluation of anticancerous and related drugs: European and American experiences and perspectives]
J C Soria, M Marty
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependency
J Remon, J C Soria
Bulletin Du Cancer
|
January 22, 1998
[Telomeres, telomerase and cancer]
J C Soria, O Rixe
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
The continuum of care for ALK-positive NSCLC: from diagnosis to new treatment options - an overview
B Solomon, J-C Soria
Bulletin Du Cancer
|
February 15, 2001
[Telomerase, a universal target in immunotherapy strategies against tumor?]
R Rousseau, J C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 24, 2015
'Statistical controversies in clinical research': a new series in Annals of Oncology
J-C Soria, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2011
Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
J-C Soria, E Deutsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Phase I trials in oncology: a new era has started
S Postel-Vinay, J-C Soria
Page
of 59
Search research articles
Search
Showing results (11-20 of 587) with videos related to
Sort By:
Page
of 59
Pathologie-Biologie
|
November 1, 1974
[Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen]
J Soria, C Soria
The New England Journal of Medicine
|
December 26, 2001
Anticoagulation for idiopathic deep-vein thrombosis
J P Kévorkian, C Soria
Bulletin Du Cancer
|
December 28, 1999
[Evaluation of anticancerous and related drugs: European and American experiences and perspectives]
J C Soria, M Marty
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependency
J Remon, J C Soria
Bulletin Du Cancer
|
January 22, 1998
[Telomeres, telomerase and cancer]
J C Soria, O Rixe
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
The continuum of care for ALK-positive NSCLC: from diagnosis to new treatment options - an overview
B Solomon, J-C Soria
Bulletin Du Cancer
|
February 15, 2001
[Telomerase, a universal target in immunotherapy strategies against tumor?]
R Rousseau, J C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 24, 2015
'Statistical controversies in clinical research': a new series in Annals of Oncology
J-C Soria, M Buyse
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2011
Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
J-C Soria, E Deutsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Phase I trials in oncology: a new era has started
S Postel-Vinay, J-C Soria
Page
of 59